Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epoetin Alfa in Friedreich's Ataxia
NCT00631202Phase 2Completed
- Sponsor
- University of Naples Federico II
- Start
- Feb 2008
- Primary completion
- Dec 2008
- Modality
- Biologic, rProtein (Recombinant Protein)
- Countries
- 1
01
Overview
A Phase 2 trial of epoetin alfa in Friedreich's ataxia (FA), sponsored by University of Naples Federico II. Started Feb 2008; status: completed.
02
Drugs
epoetin alfa
03
Conditions
Friedreich's ataxia (FA)
Beyond the preview
Go deeper on NCT00631202.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00631202.